Home  /  Resource Library  /  Real world use and acceptance of biosimilar monoclonal antibodies of rituximab in oncology practice in the USA

Real world use and acceptance of biosimilar monoclonal antibodies of rituximab in oncology practice in the USA

Study examined uptake of rituximab biosimilars treatment of lymphomas in the United States.